Drug companies pay PDUFA user fees (the 1993 Prescription Drug User Fee Act, renewed repeatedly) to speed FDA review, which shows they do not primarily seek to slow the FDA for anti-competitive reasons.

factualpending

Speaker

Richard Epstein

Evidence Quote

“The drug companies will actually pay the FDA a user fee in order to get quicker expedition of the products coming into market”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...